Article
Veterinary Pathology Pancreatic Extracellular Matrix ECM Remodeling Canine Pancreatitis Pancreatic Fibrosis Matrix Metalloproteinases Pancreatic Pathology Fibronectin Laminin Collagen Tissue Remodeling Beta Cell Survival

Why the Pancreatic Extracellular Matrix Matters in Canine Pancreatitis and Diabetes

The extracellular matrix (ECM) is often viewed simply as the structural framework that supports tissues. In reality, it is a highly dynamic component of the pancreas that actively regulates cellular behaviour, tissue integrity, and organ function. For practicing veterinarians, understanding the ECM provides valuable insight into why pancreatic diseases such as pancreatitis and diabetes mellitus progress beyond the initial injury and why tissue remodeling can influence long-term pancreatic function. 

The pancreatic ECM undergoes continuous remodeling under physiological conditions. However, when this balance is disrupted during disease, alterations in matrix composition can contribute to fibrosis, cellular dysfunction, and progressive loss of both endocrine and exocrine function1

The Extracellular Matrix: An Active Regulator of Pancreatic Function 

Rather than serving solely as a physical scaffold, the ECM regulates multiple cellular activities, including growth, migration, differentiation, survival, homeostasis, and morphogenesis1,2. It consists of an interconnected network of macromolecules, primarily collagens, elastin, fibronectin, laminin, glycosaminoglycans (GAGs), proteoglycans, and other glycoproteins1,3

Within the pancreas, the ECM surrounding the islets contains several collagen types, including I, II, III, IV, V, and VI, together with laminin, fibrin, and fibronectin1,4. These components contribute to structural stability while also influencing cell adhesion, cytoskeletal organization, and communication between endocrine and exocrine tissues1

This close interaction between cells and their surrounding matrix helps maintain normal pancreatic function and supports the survival of hormone-producing cells. 

Matrix Components That Influence Endocrine Function 

Several ECM proteins directly influence pancreatic endocrine activity. 

Fibronectin interacts with integrin and non-integrin receptors on pancreatic islets, promoting the expression of endocrine differentiation markers including insulin 2, glucagon, Pdx1, and Pax61,4. Laminin similarly supports endocrine cell function by stimulating the expression of transcription factors and hormones such as Pdx1, insulin 1, insulin 2, glucagon, somatostatin, and GLUT-2 while activating protein kinase B (Akt) and extracellular signal-regulated kinase (ERK), both of which regulate cellular metabolism1

Fibrin also contributes to pancreatic homeostasis by regulating αvβ3 integrin expression, helping prevent apoptosis of pancreatic beta cells1,5

The importance of these interactions extends beyond structural support. Functional communication between pancreatic cells and the ECM helps maintain beta-cell viability and reduces cellular apoptosis, emphasizing the importance of preserving matrix integrity during both physiological adaptation and disease progression1

When ECM Remodeling Becomes Pathological1 

ECM remodeling is a tightly regulated process involving synthesis, degradation, reassembly, and replacement of matrix components to preserve tissue homeostasis. Under pathological conditions, however, this balance may be lost. 

Matrix metalloproteinases (MMPs) play a major role in ECM degradation and remodeling, participating in organ development, repair, and tissue remodeling. Their activity normally remains low but increases significantly during tissue injury. 

In pancreatic disease, oxidative stress activates MMPs while promoting fibrosis. Progressive accumulation of collagen and fibronectin leads to loss of matrix elasticity, increased tissue stiffness, impaired capillary and ductal architecture, reduced cellular migration, acinar cell loss, and impaired diffusion of hormones such as insulin. 

Pancreatic stellate cells further accelerate fibrosis after activation, synthesizing type I and III collagens together with fibronectin. This fibrotic remodeling has been recognized as a common pathway in chronic pancreatic disease and contributes to destruction of normal tissue architecture and organ function. 

Disease-Specific Remodeling in Pancreatitis and Diabetes 

Certain remodeling pathways are particularly relevant during pancreatic disease progression. Both acute and chronic pancreatitis are associated with increased expression of MMP-9, following intra-acinar activation of trypsinogen1

Transforming growth factor-β (TGF-β) also influences ECM remodeling by regulating matrix protein expression while suppressing MMP-2 activity, promoting collagen and fibronectin deposition. During insulin-resistant diabetes, increased TGF-β/Smad3 signaling contributes to β-cell apoptosis, reduced β-cell mass, impaired glucose tolerance, and progressive β-cell dysfunction1,6

These molecular alterations demonstrate how ECM remodeling extends beyond structural change to influence endocrine function and disease progression. 

Practical Clinical Insights 

For practicing veterinarians, pancreatic disease should be viewed as more than inflammation or endocrine dysfunction alone. The extracellular matrix actively participates in cellular survival, tissue repair, fibrosis, and disease progression. Appreciating the role of ECM remodeling helps explain why chronic pancreatic disorders can result in progressive structural damage, declining endocrine and exocrine function, and long-term clinical consequences. Recognizing these biological processes strengthens the understanding of pancreatic pathology and provides valuable context as regenerative therapeutic approaches continue to evolve. 

References 

  1. Pantoja BT, Carvalho RC, Miglino MA, Carreira AC. The canine pancreatic extracellular matrix in diabetes mellitus and pancreatitis: its essential role and therapeutic perspective. Animals. 2023 Feb 15;13(4):684. https://www.mdpi.com/2076-2615/13/4/684 
  1. Clause KC, Barker TH. Extracellular matrix signaling in morphogenesis and repair. Current opinion in biotechnology. 2013 Oct 1;24(5):830-3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3773047/pdf/nihms476651.pdf 
  1. Faulk DM, Wildemann JD, Badylak SF. Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix. Journal of clinical and experimental hepatology. 2015 Mar 1;5(1):69-80. https://pmc.ncbi.nlm.nih.gov/articles/PMC4415199/pdf/main.pdf 
  1. Llacua LA, Faas MM, de Vos P. Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia. 2018 Jun;61(6):1261-72. https://link.springer.com/content/pdf/10.1007/s00125-017-4524-8.pdf 
  1. Riopel M, Stuart W, Wang R. Fibrin improves beta (INS-1) cell function, proliferation and survival through integrin αvβ3. Acta biomaterialia. 2013 Sep 1;9(9):8140-8. https://doi.org/10.1016/j.actbio.2013.05.035 
  1. Lee JH, Mellado-Gil JM, Bahn YJ, Pathy SM, Zhang YE, Rane SG. Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling. Cell Death & Disease. 2020 Mar 13;11(3):184. https://www.nature.com/articles/s41419-020-2365-8.pdf